摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3,4-dihydroxy-phenyl)-3-hydroxy-2-methylamino-propionic acid | 89754-21-2

中文名称
——
中文别名
——
英文名称
3-(3,4-dihydroxy-phenyl)-3-hydroxy-2-methylamino-propionic acid
英文别名
3-(3,4-Dihydroxy-phenyl)-3-hydroxy-2-methylamino-propionsaeure;N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine;3-(3,4-Dihydroxyphenyl)-3-hydroxy-2-(methylamino)propanoic acid
3-(3,4-dihydroxy-phenyl)-3-hydroxy-2-methylamino-propionic acid化学式
CAS
89754-21-2;89754-26-7;92843-36-2;92843-37-3;96554-46-0;110013-50-8;110013-51-9
化学式
C10H13NO5
mdl
——
分子量
227.217
InChiKey
RPXZFIAFSLMEJW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.7
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    110
  • 氢给体数:
    5
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Threo-adrenalinecarboxylic acid, processes for the production thereof, and pharmaceutical compositions thereof
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP0112606A1
    公开(公告)日:1984-07-04
    DL- and L-Threo-3-(3,4-dihydroxyphenyl)-N-methyl-serine which may also be termed as DL- and L-threo-adrenalinecarboxylic acid are now provided, which are new compounds useful for therapeutic treatment of Parkinson's disease and mental depression disease. DL-Adrenalinecarboxylic acid may be produced by a new process comprising reacting glycine with O-protected 3,4-dihydroxybenzaldehyde, hydrolyzing the resultant reaction product under acidic conditions to form O-protected DL-3-(3,4-dihydroxyphenyl)serine, isolating the O-protected DL-3-(3,4-dihydroxyphenyl)serine into the threo isomer and the erythro isomer by recrystallization from a suitable organic solvent, introducing an unsubstituted or substituted benzyl group into the 2-amino group of the resulting O-protected DL-threo-3-(3,4-dihydroxyphenyl)serine, then N-methylating the resulting O-protected DL-threo-3-(3,4-dihydroxyphenyl)-N-benzylserine,and removing the O-protecting groups as well as the unsubstituted or substituted benzyl group at the 2-methylamino group of the N-methylation product. L-threo-Adrenalinecarboxylic acid may be produced by a new process comprising introducing a p-methoxybenzyloxycarbonyl group into the 2-amino group of the O-protected DL-threo-3-(3,4-dihydroxyphenyl)serine obtained as an intermediate product, optically resolving the resultant 0-protected DL-threo-3-(3,4-dihydroxyphenyl)-N-p-methoxybenzyloxycarbonyl-serine by reacting the latter with an optically active amine and recrystallizing the resultant amine salt products from a suitable organic solvent, removing the p-methoxybenzyloxycarbonyl group from the resultant O-protected L-threo-(3,4-dihydroxyphenyl)-N-p-methoxybenzyloxycarbonyl-serine, reacting the resultant O-protected L-threo-(3,4-dihydroxyphenyl)serine with dimethyl sulfate in dry acetone to form an O-protected L-threo-(3,4-dihydroxyphenyl)-N-methylserine methyl ester, saponifying this methyl ester and then removing the O-protecting groups from the saponification product.
    现在提供的 DL-和 L-苏-3-(3,4-二羟基苯基)-N-甲基丝氨酸也可称为 DL-和 L-苏-肾上腺素羧酸,它们是可用于治疗帕金森病和精神抑郁症的新化合物。DL-肾上腺素羧酸可通过一种新工艺生产,该工艺包括使甘氨酸与 O-保护的 3,4-二羟基苯甲醛反应,在酸性条件下水解反应产物,形成 O-保护的 DL-3-(3,4-二羟基苯基)丝氨酸,通过从合适的有机溶剂中重结晶,将 O-保护的 DL-3-(3,4-二羟基苯基)丝氨酸分离成苏氨酸异构体和赤藓醇异构体、将未取代或取代的苄基引入到所得 O-保护的 DL-苏-3-(3,4-二羟基苯基)丝氨酸的 2-氨基中,然后将所得 O-保护的 DL-苏-3-(3,4-二羟基苯基)-N-苄丝氨酸 N-甲基化,并去除 O-保护基团以及 N-甲基化产物的 2-甲基氨基上的未取代或取代的苄基。 L-硫代肾上腺素羧酸可通过一种新工艺生产,该工艺包括在作为中间产物获得的 O-保护基 DL-硫代-3-(3,4-二羟基苯基)丝氨酸的 2-氨基上引入对甲氧基苄氧羰基、通过使 0-保护的 DL-苏氨酰-3-(3,4-二羟基苯基)-N-对甲氧基苄氧羰基丝氨酸与光学活性胺反应,并从合适的有机溶剂中重结晶所得到的胺盐产物,从而对 0-保护的 DL-苏氨酰-3-(3,4-二羟基苯基)-N-对甲氧基苄氧羰基丝氨酸进行光学解析、从得到的 O-保护的 L-硫代-(3,4-二羟基苯基)-N-对甲氧基苄氧羰基丝氨酸中除去对甲氧基苄氧羰基,将得到的 O-保护的 L-硫代-(3、在干丙酮中与硫酸二甲酯反应,形成 O-保护的 L-硫代-(3,4-二羟基苯基)-N-甲基丝氨酸甲酯,将该甲酯皂化,然后从皂化产物中去除 O-保护基团。
  • A process for producing an optically active 3-(3,4-dihydroxphenyl) serine and a proteced derivative thereof
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP0141613A2
    公开(公告)日:1985-05-15
    N-acyl-DL-3-(3,4-dihydroxyphenyl)serine or a catecholic hydroxyl-protected derivative thereof is stereospecifically de-acylated by reaction with a microorganism of Streptomyces or Streptoverticillium having an acylase or with an extract of said microorganism containing said acylase, to produce L-3-(3,4-dihydroxyphenyl)serine or the hydroxyl-protected derivative thereof, with the N-acyl-D-3-(3,4-dihydroxyphenyl)serine compound remaining unaltered. The L-3-(3,4-dihydroxyphenyl)-serine compound so produced can be separated from the N-acyl-D-3-(3,4-dihydroxyphenyl)serine compound owing to its different properties.
    将 N-酰基-DL-3-(3,4-二羟基苯基)丝氨酸或其羟基保护的儿茶酚衍生物与具有酰化酶的链霉菌或链孢霉微生物或含有所述酰化酶的所述微生物提取物反应,进行立体定向脱酰化、生成 L-3-(3,4-二羟基苯基)丝氨酸或其羟基保护衍生物,而 N-酰基-D-3-(3,4-二羟基苯基)丝氨酸化合物保持不变。由于 N-酰基-D-3-(3,4-二羟基苯基)丝氨酸化合物具有不同的性质,因此可以将这样制得的 L-3-(3,4-二羟基苯基)丝氨酸化合物与 N-酰基-D-3-(3,4-二羟基苯基)丝氨酸化合物分开。
  • N-Methylphenylserine alkyl ester derivatives and uses thereof
    申请人:ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI
    公开号:EP0218440A2
    公开(公告)日:1987-04-15
    As new compounds N-methyl-3-(3,4-dihydroxyphenyl)serine alkyl esters. These are effective as a-adrenergic and β-adrenergic agenta to stimulate the a-adrenergic and β-adrenergic functions of the central nervous system of mammalian animals. Such compounds can be useful for therapeutic treatment of disorders as invoked by reduced biological activities or functions of the a-and/or β-adrenergic neurons. N-methyl-L-threo-3-(3,4-dihydroxyphenyl)serine (C1 - Cs) alkyl esters are preferred amongst the new compounds of this invention.
    作为新化合物的 N-甲基-3-(3,4-二羟基苯基)丝氨酸烷基酯。这些化合物作为 a-肾上腺素能和β-肾上腺素能制剂,可有效刺激哺乳动物中枢神经系统的 a-肾上腺素能和β-肾上腺素能功能。此类化合物可用于治疗因 a 和/或 β 肾上腺素能神经元的生物活性或功能降低而引起的疾病。在本发明的新化合物中,N-甲基-L-苏-3-(3,4-二羟基苯基)丝氨酸(C1-Cs)烷基酯是首选。
  • Cyclic peptide derivative, method for preparing same and composition thereof
    申请人:NATIONAL UNIVERSITY CORPORATION, IWATE UNIVERSITY
    公开号:US10654890B2
    公开(公告)日:2020-05-19
    Provided is a cyclic peptide derivative which is derived from Paecilomyces tenuipes having an astrocyte proliferative activity, or a salt thereof.
    本文提供了一种从具有星形胶质细胞增殖活性的栉水母菌(Paecilomyces tenuipes)中提取的环肽衍生物或其盐。
  • UMEHDZAVA, XAMAO;NAGATSU, TOSIXARU;NARAXAYASI, XIROTARO;TAKEHUTI, TOMIO;I+
    作者:UMEHDZAVA, XAMAO、NAGATSU, TOSIXARU、NARAXAYASI, XIROTARO、TAKEHUTI, TOMIO、I+
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物